NEW YORK (GenomeWeb News) - Cellumen said today that it will collaborate with the Mayo Foundation for Medical Education and Research to apply the company’s cellular systems biology approach to breast cancer patient stratification.
Cellumen said that the goal of the project is to create a breast cancer patient profile test to help improve disease treatment and diagnosis.
"We are treating breast tumors as a 'system' within the breast cancer patient," said Cellumen's CEO, Lansing Taylor.
The research will involve multiplexing a "combination of breast cancer biomarkers and migratory immune cell biomarkers," Taylor added.
Cellumen has ongoing research programs and business activities in patient profiling and in drug discovery and development.